Bethany Wangelin to Veterans
This is a "connection" page, showing publications Bethany Wangelin has written about Veterans.
Connection Strength
1.021
-
When chaos is the norm: How some veterans with PTSD are continuing to engage in trauma-focused treatments during the COVID-19 pandemic. Psychol Trauma. 2020 Aug; 12(S1):S69-S70.
Score: 0.410
-
Improving function through primary care treatment of PTSD: The IMPACT study protocol. Contemp Clin Trials. 2022 09; 120:106881.
Score: 0.119
-
Enhancing prolonged exposure therapy for PTSD among veterans with oxytocin: Design of a multisite randomized controlled trial. Contemp Clin Trials. 2020 08; 95:106074.
Score: 0.103
-
An adjunctive human-animal interaction intervention for veterans with PTSD: study protocol for a randomized controlled trial. Trials. 2019 Dec 27; 20(1):786.
Score: 0.100
-
TAKING THE PULSE OF PROLONGED EXPOSURE THERAPY: PHYSIOLOGICAL REACTIVITY TO TRAUMA IMAGERY AS AN OBJECTIVE MEASURE OF TREATMENT RESPONSE. Depress Anxiety. 2015 Dec; 32(12):927-34.
Score: 0.075
-
PTSD in active combat soldiers: to treat or not to treat. J Law Med Ethics. 2014; 42(2):161-70.
Score: 0.066
-
Enhancing exposure therapy for PTSD with yohimbine HCL: protocol for a double-blind, randomized controlled study implementing subjective and objective measures of treatment outcome. Contemp Clin Trials. 2013 Nov; 36(2):319-26.
Score: 0.064
-
Emotional Processing of Imaginal Exposures Predicts Symptom Improvement: Therapist Ratings Can Assess Trajectory in Prolonged Exposure for Posttraumatic Stress Disorder. J Trauma Stress. 2020 06; 33(3):338-344.
Score: 0.025
-
Hyperarousal Symptoms Explain the Relationship Between Cognitive Complaints and Working Memory Performance in Veterans Seeking PTSD Treatment. J Head Trauma Rehabil. 2018 Jul/Aug; 33(4):E10-E16.
Score: 0.022
-
Augmenting treatment efficiency in exposure therapy for PTSD: a randomized double-blind placebo-controlled trial of yohimbine HCl. Cogn Behav Ther. 2018 09; 47(5):351-371.
Score: 0.022
-
Health service utilization before and after evidence-based treatment for PTSD. Psychol Serv. 2013 Nov; 10(4):401-9.
Score: 0.015